Similar articles

• Reply: Infective Endocarditis, Gentamicin, and Vestibular Toxicity.

  Cahill TJ, Prendergast BD. Cahill TJ, et al. J Am Coll Cardiol. 2017 Jul 11;70(2):298-299. doi: 10.1016/j.jacc.2017.04.057. J Am Coll Cardiol. 2017. PMID: 28683976 No abstract available.
• Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome.

  Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, Moser C, Sogaard P, Arpi M, Bruun NE. Dahl A, et al. Circulation. 2013 Apr 30;127(17):1810-7. doi: 10.1161/CIRCULATIONAHA.112.001170. Epub 2013 Mar 29. Circulation. 2013. PMID: 23543002
• Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis.

  Lee PY, Das SS. Lee PY, et al. Postgrad Med J. 1995 Feb;71(832):117-9. doi: 10.1136/pgmj.71.832.117. Postgrad Med J. 1995. PMID: 7724425 Free PMC article.
• Aminoglycoside resistant enterococcal endocarditis.

  Eliopoulos GM. Eliopoulos GM. Infect Dis Clin North Am. 1993 Mar;7(1):117-33. Infect Dis Clin North Am. 1993. PMID: 8463648 Review.
• Treatment of endocarditis due to Proteus species: a literature review.

  Kalra A, Cooley C, Tsigrelis C. Kalra A, et al. Int J Infect Dis. 2011 Apr;15(4):e222-5. doi: 10.1016/j.ijid.2010.12.002. Epub 2011 Jan 14. Int J Infect Dis. 2011. PMID: 21237686 Review.